• Amylin Pharmaceuticals submitted an NDA for exanatide (Byetta) LAR and saw its stock price rise about 6%. The submission comes one day after the company said it was axing 200 reps. [WSJ]

• A Pfizer employee has contracted Swine flu!! [NBC Connecticut]

• The recent axes at Amylin are somewhat of a 180 from what the company told Carl Icahn last month. [BNET Pharma]

• Abbott is suing Johnson & Johnson over new Simponi drug. [Bloomberg]

• Sanofi is setting up a $265M biotech plant, seeks partnerships. [Reuters]

• India’s Jubilant Biosys has inked a new R&D alliance with AstraZeneca, deal valued at $220M. [FierceBiotech]

• Roche wins approval for Avastin to treat brain cancer (glioblastoma multiforme). [Bloomberg]

• Finally, 23andMe has raised $11M of an anticipated $24.26M second round of financing. The company was cofounded by Anne Wojcicki, wife of Google co-founder Sergey Brin. [VentureBeat]

Image from abcnews

Related Posts